Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1

Journal of Immunological Methods

Volumn 277, Issue 1-2, 2003, Pages 157-169

  Wu, Chuanjing ^a   Yang, Rong Jiang ^b   Zhou, Ji ^b   Bao, Shing ^b   Zou, Li ^a   Zhang, Pinggan ^a   Mao, Yongrong ^d   Wu, Jianping ^d   He, Qimin ^c  

^a WUHAN UNIVERSITY   (China)

^b Jason Med Group (Far East) Limited   (Hong Kong)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d NONE

Author keywords

Anti TK1 IgY antibody; Dot blot; Egg yolk immunoglobulin (IgY); Enhanced chemiluminescence (ECL); S TK1 (serum TK1); Thymidine kinase 1 (TK1)

Indexed keywords

EGG YOLK IMMUNOGLOBULIN ANTIBODY; GLYCYLGLUTAMINYLPROLYLALANYLGLYCYLPHENYLALANYLASPARTYLASPARAGINYLLYSYLGLUTA MYLASPARAGINYLCYSTEINYLPROLYLVALYLPROLYLGLYCYLLYSYLPROLYLGLYCYLGLUTAMYLALANYLVAL YLALANYLALANYLARGININE; IMMUNOGLOBULIN ANTIBODY; PEPTIDE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AFFINITY CHROMATOGRAPHY; AGED; ANTIBODY PRODUCTION; ARTICLE; BREAST CARCINOMA; CARBOXY TERMINAL SEQUENCE; CHEMOLUMINESCENCE; CHICKEN; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; EGG YOLK; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME SUBUNIT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; STOMACH CANCER; THYROID CARCINOMA; WESTERN BLOTTING;

AVES; GALLUS GALLUS; MAMMALIA;

EID: 0037532754     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00062-0     Document Type: Article

References (35)

1. Akita E.M., Nakai S. Immunoglobulins from egg yolk: isolation and purification. J. Food Sci. 57:1992;629.
2. Anér E.S., Eriksson S. Mammalian deoxynucleoside kinase. Pharm. Ther. 67:1995;155.
3. Axdorph U., Sjoberg J., Grimfors G., Landgren O., Porwit-MacDonald A., Bjorkholm M. Biological markers may add to prediction of outcome achieved by the international prognostic score in Hodgkin's disease. Ann. Oncol. 11:2000;1405.
4. Bradshaw H.D. Jr., Deininger P.L. Human thymidine kinase gene: molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells. Mol. Cell. Biol. 4:1984;2316.
5. Brent T.P. Periodicity of DNA synthetic enzymes during the HeLa cell cycle. Cell Tissue Kinet. 4:1971;297.
6. Camenisch G., Tini M., Chilov D., Kvietikova I., Srinivas V., Caro J., Spielmann P., Wenger R.H. General application of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised against the hypoxia-inducible factor 1α FASEB J. 13:1999;81.
7. Fortgens P.H., Dennison C., Elliott E. Anti-cathepsin chicken antibody: characterization, cross-species reactivity and application in immunogold labelling of human splenic neutrophils and fibroblasts. Immunophamacology. 36:1997;305.
8. Fujiwaki R., Hata K., Moriyama M., Iwanari O., Katabuchi H., Okamura H., Miyazaki K. Clinical value of thymidine kinase in patients with cervical carcinoma. Oncology. 61:2001;47.
9. Gronowitz J.S., Hagberg H., Källander C.F.R., Simonsson B. The use of serum deoxythymidine kinase as a prognostic marker in the monitoring of patients with non-Hodgkin's lymphoma. Br. J. Cancer. 47:1983;487-495.
10. Gronowitz J.S., Källander F.R., Diderholm H., Hagberg H., Petterssion U. Application of an in vivo assay for serum thymidine kinase: results on viral disease and malignancies in humans. Int. J. Cancer. 15:1984;5.
11. Hallek M., Wanders L., Strohmeyer S., Emmerich B. Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications. Ann. Hematol. 65:1992;1.
12. Hallek M., Langenmayer I., Nerl C., Knauf W., Dietzfelbinger H., Adorf D., Ostwald M., Busch R., Kuhn-Hallek I., Thiel E., Emmerich B. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood. 93:1999;1732.
13. He Q., Skog S., Welander I., Tribukait B. Enzyme kinetics of thymidine isoenzymes of Ehrlich ascites tumour. Anticancer Res. 10:1990;1257.
14. He Q., Skog S., Tribukait B. Cell cycle related studies on thymidine kinase and its isoenzymes in Ehrlich ascites tumours. Cell Prolif. 24:1991;3.
15. He Q., Wang N., Skog S., Eriksson S., Tribukait B. Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Eur. J. Cell Biol. 70:1996;117.
16. He Q., Zou L., Zhang P.A., Lui J.X., Skog S., Fornander T. The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody. Int. J. Biol. Marker. 15:2000;139.
17. He Q., Skog S., Welander I., Tribukait B. X-irradiation effects on thymidine kinase (TK): I. TK1 TK2 in normal and malignant cells. Cell Prolif. 35:2002;83.
18. Johnson L.F., Rao L.G., Muench A.J. Regulation of thymidine kinase enzyme level in serum-stimulated mouse 3T6 fibroblasts. Exp. Cell Res. 138:1982;78.
19. Kauffman M.G., Kelly T.J. Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis. Mol. Cell. Biol. 11:1991;2538.
20. Kuroiwa N., Nakayama M., Fufuda T., Fufui H., Ohwada H., Hiwasa T., Fujimura S. Specific recognition of cytosolic thymidine kinase in the human lung tumor by monoclonal antibody raised against recombinant human thymidine kinase. J. Immunol. Methods. 253:2001;1.
21. Kwoh T.J., Engler J.A. The nucleotide sequence of the chicken thymidine kinase and relationship of its predicted polypeptide to that of the vaccinia virus thymidine kinase. Nucleic Acids Res. 12:1984;3959.
22. Lin P.F., Lieberman H.B., Yeh D.B., Xu T., Zhao S.Y., Ruddle F.H. Molecular cloning and structural analysis of murine thymidine kinase genomic and cDNA sequences. Mol. Cell. Biol. 5:1985;3149.
23. Mao Y.R., Wu J.P., Wang N., He J.X., Wu C.J., He Q., Skog S. A comparison study: immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer. Cancer Investig. 20:2002;922.
24. Morrison S.L., Mohammed M.S., Wims L.A., Trinh R., Etches R. Sequence in antibody moleculars important for receptor-mediated transport into the chicken egg yolk. Mol. Immunol. 38:2001;619.
25. Munch-Petersen B., Tyrsted G., Cloos L. Reversible ATP-dependent transition between two forms of human cytosolic thymidine kinase with different enzymatic properties. J. Biol. Chem. 268:1993;15621.
26. Sherley J.L., Kelly T.J. Regulation of human thymidine kinase during the cell cycle. J. Biol. Chem. 263:1988;8350.
27. Sherley J.L., Kelly T.J. Human cytosolic thymidine kinase. Purification and physical characterization of the enzyme from HeLa cells. J. Biol. Chem. 263:1988;375.
28. Stuart P., Ito O., Conrad S.E. Induction of cellular thymidine kinase occurs at the mRNA level. Mol. Cell. Biol. 5:1985;1490.
29. Tini M., Jewell U.R., Camenisch G., Chilov D., Gassmann M. Generation and application of chicken egg-yolk antibodies. Comp. Biochem. Physiol., Part A. 131:2002;569.
30. Wang N., He Q., Skog S., Eriksson S., Tribukait B. Investigation on cell proliferation with a new antibody against thymidine kinase 1. Anal. Cell. Pathol. 23:2001;11.
31. Warr Q.W., Magor K.F., Higgins D.A. IgY: clues to the origins of modern antibodies. Immunol. Today. 16:1995;392.
32. Wu J.P., Mao Y.R., He L.X., Wang N., Wu C.J., He Q., Skog S. Comparison study on the expression of cytosolic thymidine kinase and proliferating cell nuclear antigen in colorectal carcinoma. Anticancer Res. 6:2000;4867.
33. Zhang F., Li H., Pendleton A.R., Robison J.G., Monson K.O., Murray B.K., O'Neill K.L. Thymidine kinase 1 immunoassay: a potential maker for breast cancer. Cancer Detec. Prev. 25:2001;8.
34. Zhao Y., Rabbani H., Shimizu A., Hammarström L. Mapping of the chicken immunoglobulin heave-chain constant region gene locus reveals an inverted α gene upstream of condensed υ gene. Immunology. 101:2000;348.
35. Zou L., Zhang P.G., Zou S., Li Y., He Q. The half-life of cytosolic thymidine kinase in serum by ECL dot blot: a potential marker for monitoring the response to surgery of patients with gastric cancer. Int. J. Biol. Marker. 17:2002;135.